GAMMA Investing’s Tonix Pharmaceuticals TNXP Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q3
$2.45K Sell
252
-36
-13% -$425 ﹤0.01% 3887
2026
Q2
$3.68K Buy
288
+4
+1% +$52 ﹤0.01% 3598
2026
Q1
$3.9K Buy
+284
New +$4.37K ﹤0.01% 3457

Other funds holding TNXP

GAMMA Investing's TNXP Position: Q3 2026 in Review

GAMMA Investing reduced its Tonix Pharmaceuticals (TNXP) stake by 13% in Q3 2026, selling an estimated $425 and leaving 252 shares worth $2.45K. The position accounts for ﹤0.01% of the portfolio, ranked #3887.

GAMMA Investing first reported a position in TNXP in Q1 2026 and has held it in 3 quarters since. The position peaked at $3.9K in Q1 2026. 113 funds tracked by Wall St. Rank hold TNXP as of Q3 2026.

  • GAMMA Investing held 252 shares of Tonix Pharmaceuticals worth $2.45K as of Q3 2026.
  • GAMMA Investing sold 36 Tonix Pharmaceuticals shares in Q3 2026, an estimated $425.
  • Tonix Pharmaceuticals made up ﹤0.01% of GAMMA Investing's portfolio in Q3 2026, its #3887 holding.
  • GAMMA Investing first reported a position in Tonix Pharmaceuticals in Q1 2026 and has held it in 3 quarters since.
  • GAMMA Investing's Tonix Pharmaceuticals position peaked at $3.9K in Q1 2026.
  • 113 funds tracked by Wall St. Rank held Tonix Pharmaceuticals as of Q3 2026.

Based on GAMMA Investing's 13F filing for Q3 2026, filed 8 Oct 2026.